Serelaxin: New Investigational Treatment in Acute Heart Failure

ISSN: 1875-6182 (Online)
ISSN: 1871-5257 (Print)

Volume 15, 3 Issues, 2017

Download PDF Flyer

Cardiovascular & Hematological Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Cardiovascular & Hematological Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Debabrata Mukherjee
Department of Internal Medicine Texas Tech University
El Paso, TX

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Serelaxin: New Investigational Treatment in Acute Heart Failure

Cardiovascular & Hematological Agents in Medicinal Chemistry, 11(3): 243-248.

Author(s): Sarmad Said and Debabrata Mukherjee.

Affiliation: Department of Internal Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, 4800 Alberta Avenue, El Paso, Texas, USA 79905.


Over the last decade several pharmacological approaches for acute heart failure have been introduced, however, no drastic change in the medical management apart from device-dependent therapy was observed. Essentially vasodilators and diuretics as primary therapy in acute heart failure was discussed and encouraged in the guidelines but no breakthrough in the treatment of acute heart failure was achieved. More recently, clinical trials of relaxin and its recombinant form, i.e., serelaxin in patients with acute heart failure demonstrated a significant clinical improvement with favorable safety and tolerability profile in symptomatic heart failure patients. This report reviews the potential beneficial effects and role of serelaxin in the setting of acute heart failure.


Acute heart failure, cardiac failure, cardiovascular diseases, cognitive impairment, dyspnea, hospitalized patients, ischemic cardiomyopathy, non-ischemic cardiomyopathy, relaxin, serelaxin, vasodilator.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 11
Issue Number: 3
First Page: 243
Last Page: 248
Page Count: 6
DOI: 10.2174/1871525711666131128144132
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science